Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.
Read more on NPR
Saturday, 2 May 2020
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.